Literature DB >> 7607989

Role of endolymphatic anion transport in forskolin-induced Cl- activity increase of scala media.

I Kitano1, N Mori, T Matsunaga.   

Abstract

To determine the role of anion transport in the forskolin-induced Cl- increase of scala media (SM), effects of forskolin on the EP (endocochlear potential) and Cl- activity (ACl) in SM were examined with double-barrelled Cl(-)-selective microelectrodes. The experiments were carried out on guinea pig cochleae, using a few anion transport inhibitors: IAA-94 for a Cl- channel blocker, bumetanide (BU) for an Na+/K+/2Cl- cotransport blocker, and SITS and DIDS for Cl-/HCO3- exchange blockers. The application of forskolin (200 microM) into scala vestibuli (SV) caused a 20 mEq increase of endolymphatic ACl and a 15 mV elevation of EP, and IAA-94 with forskolin completely abolished these responses. Although each application of BU, SITS or DIDS did not completely suppress EP elevation, the concurrent application of these inhibitors completely suppressed EP with endolymphatic ACl increase. The results indicate the involvement of Cl- channels, Na+/K+/2Cl- cotransport and Cl-/HCO3- exchange in forskolin-induced increase of ACl and EP. The role of adenylate cyclase activation and Cl- transport in endolymph homeostasis was discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7607989     DOI: 10.1016/0378-5955(94)00187-u

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  3 in total

Review 1.  Endolymphatic hydrops: pathophysiology and experimental models.

Authors:  Alec N Salt; Stefan K Plontke
Journal:  Otolaryngol Clin North Am       Date:  2010-10       Impact factor: 3.346

2.  Acute endolymphatic hydrops generated by exposure of the ear to nontraumatic low-frequency tones.

Authors:  Alec N Salt
Journal:  J Assoc Res Otolaryngol       Date:  2004-06

3.  Genetically encoded optical sensors for monitoring of intracellular chloride and chloride-selective channel activity.

Authors:  Piotr Bregestovski; Tatyana Waseem; Marat Mukhtarov
Journal:  Front Mol Neurosci       Date:  2009-12-04       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.